Physician profile
Amanda Robinson
NPI 1184139479
$884.48
in general payments reported to CMS, 2019-2025
16 companies · $314 in 2025
The $314 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $34.21 · 2021: $26.63 · 2022: $105 · 2023: $29.03 · 2024: $375 · 2025: $314.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $718.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $718.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $128.36 | 2024-2025 | Jardiance |
| Lilly USA, LLC | $111.19 | 2022-2025 | Jardiance, Mounjaro, Zepbound |
| Astrazeneca Pharmaceuticals LP | $94.52 | 2021-2024 | Farxiga, Airsupra, Breztri |
| Exact Sciences Corporation | $79.84 | 2023-2025 | Cologuard Collection Kit |
| Novo Nordisk INC | $73.95 | 2022-2025 | Wegovy |
| Pfizer INC. | $68.21 | 2024-2025 | |
| Amgen INC. | $53.51 | 2024-2025 | Repatha, Repatha, Otezla |
| Medtronic, INC. | $51.95 | 2022 | |
| Abbvie INC. | $48.74 | 2021-2025 | |
| Glaxosmithkline, LLC. | $39.43 | 2024-2025 | Pediarix, Rotarix, Bexsero |
| Upsher-Smith Laboratories LLC | $34.21 | 2019 | |
| Dynavax Technologies Corporation | $24.99 | 2025 | Heplisav-B |
| Sanofi Pasteur INC. | $24.10 | 2024 | |
| Xeris Pharmaceuticals, INC. | $22.04 | 2024 | Gvoke Hypopen |
| Merck Sharp & Dohme LLC | $15.25 | 2025 | M-M-R II, Capvaxive, Vaxelis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.19 | 2024 | Nuzyra |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Amanda Robinson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.